Mira Pharmaceuticals Inc (NASDAQ:MIRA) does about 2.23M shares in volume on a normal day but saw 4718119 shares change hands in the recent trading day. The company now has a market cap of 19.07M USD. Its current market price is $1.29, marking an increase of 14.16% compared to the previous close of $1.13. The 52 week high reached by this stock is $6.40 whilst the lowest price level in 52 weeks is $0.51.
Mira Pharmaceuticals Inc (MIRA) has a 20-day trading average at $1.1245 and the current price is -79.84% off the 52-week high compared with 152.94% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.3690 and its 200-day simple moving average is $1.1665. If we look at the stock’s price movements over the week, volatility stands at 9.72%, which decreases to 8.39% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.84 to suggest the stock is neutral.
The consensus objective for the share price is $13.31, suggesting that the stock has a potential upside of 90.31% over the period.
The current price level is 14.72%, -5.77%, and 10.59% away from its SMA20, SMA50, and SMA200 respectively, with the MIRA price moving above the 50-day SMA on current market day. Mira Pharmaceuticals Inc (MIRA) stock is up 17.27% over the week and 20.56% over the past month. Its price is 22.86% year-to-date and -42.15% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of -0.26 below consensus estimates by -0.18. The company’s next earnings report forecasts estimating quarterly EPS at -0.15 and -0.56 for whole year.
To reach the target analysts have set, the stock logically needs to grow 90.31 percent from here.
Outstanding shares total 14.78M with insiders holding 27.21% of the shares and institutional holders owning 5.03% of the company’s common stock. The company has a return on investment of -576.14% and return on equity of -748.59%. The beta has a value of 4.33. Price to book ratio is 8.59.
